Injection behaviors among injection drug users in treatment: The role of hepatitis C awareness

Philip (Todd) Korthuis, Daniel J. Feaster, Zoilyn L. Gomez, Moupali Das, Susan Tross, Katharina Wiest, Antoine Douaihy, Raul N. Mandler, James L. Sorensen, Grant Colfax, Dennis McCarty, Stephanie E. Cohen, Patricia E. Penn, Diane Lape, Lisa R. Metsch

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Injection drug use (IDU) is a primary vector for blood-borne infections. Awareness of Hepatitis C virus (HCV) infection status may affect risky injection behaviors. This study determines the prevalence of risky injection practices and examines associations between awareness of positive HCV status and risky injection behaviors. Methods: We surveyed individuals seeking treatment for substance use at 12 community treatment programs as part of a national HIV screening trial conducted within the National Drug Abuse Treatment Clinical Trials Network. Participants reported socio-demographic characteristics, substance use, risk behaviors, and HCV status. We used multivariable logistic regression to test associations between participant characteristics and syringe/needle sharing. Results: The 1281 participants included 244 (19.0%) individuals who reported injecting drugs in the past 6. months and 37.7% of IDUs reported being HCV positive. During the six months preceding baseline assessment, the majority of IDUs reported obtaining sterile syringes from pharmacies (51.6%) or syringe exchange programs (25.0%), but fewer than half of IDUs always used a sterile syringe (46.9%). More than one-third (38.5%) shared syringe/needles with another injector in the past 6. months. Awareness of positive HCV vs. negative/unknown status was associated with increased recent syringe/needle sharing (aOR 2.37, 95% CI 1.15, 4.88) in multivariable analysis. Conclusions: Risky injection behaviors remain prevalent and awareness of HCV infection was associated with increased risky injection behaviors. New approaches are needed to broadly implement HCV prevention interventions for IDUs seeking addiction treatment.

Original languageEnglish (US)
Pages (from-to)552-555
Number of pages4
JournalAddictive Behaviors
Volume37
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Syringes
Hepatitis C
Drug Users
Viruses
Hepacivirus
Needle Sharing
Injections
Pharmaceutical Preparations
Needles
Virus Diseases
Therapeutics
Needle-Exchange Programs
Drug therapy
Pharmacies
Risk-Taking
Substance-Related Disorders
Logistics
Screening
Blood
Cross-Sectional Studies

Keywords

  • Alcoholism
  • Hepatitis C
  • Injection drug use
  • Opioid-related disorders
  • Syringe/needle sharing

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Toxicology
  • Medicine (miscellaneous)

Cite this

Injection behaviors among injection drug users in treatment : The role of hepatitis C awareness. / Korthuis, Philip (Todd); Feaster, Daniel J.; Gomez, Zoilyn L.; Das, Moupali; Tross, Susan; Wiest, Katharina; Douaihy, Antoine; Mandler, Raul N.; Sorensen, James L.; Colfax, Grant; McCarty, Dennis; Cohen, Stephanie E.; Penn, Patricia E.; Lape, Diane; Metsch, Lisa R.

In: Addictive Behaviors, Vol. 37, No. 4, 04.2012, p. 552-555.

Research output: Contribution to journalArticle

Korthuis, PT, Feaster, DJ, Gomez, ZL, Das, M, Tross, S, Wiest, K, Douaihy, A, Mandler, RN, Sorensen, JL, Colfax, G, McCarty, D, Cohen, SE, Penn, PE, Lape, D & Metsch, LR 2012, 'Injection behaviors among injection drug users in treatment: The role of hepatitis C awareness', Addictive Behaviors, vol. 37, no. 4, pp. 552-555. https://doi.org/10.1016/j.addbeh.2011.12.001
Korthuis, Philip (Todd) ; Feaster, Daniel J. ; Gomez, Zoilyn L. ; Das, Moupali ; Tross, Susan ; Wiest, Katharina ; Douaihy, Antoine ; Mandler, Raul N. ; Sorensen, James L. ; Colfax, Grant ; McCarty, Dennis ; Cohen, Stephanie E. ; Penn, Patricia E. ; Lape, Diane ; Metsch, Lisa R. / Injection behaviors among injection drug users in treatment : The role of hepatitis C awareness. In: Addictive Behaviors. 2012 ; Vol. 37, No. 4. pp. 552-555.
@article{72dbaa4e6e774498b831fb9454211f9f,
title = "Injection behaviors among injection drug users in treatment: The role of hepatitis C awareness",
abstract = "Background: Injection drug use (IDU) is a primary vector for blood-borne infections. Awareness of Hepatitis C virus (HCV) infection status may affect risky injection behaviors. This study determines the prevalence of risky injection practices and examines associations between awareness of positive HCV status and risky injection behaviors. Methods: We surveyed individuals seeking treatment for substance use at 12 community treatment programs as part of a national HIV screening trial conducted within the National Drug Abuse Treatment Clinical Trials Network. Participants reported socio-demographic characteristics, substance use, risk behaviors, and HCV status. We used multivariable logistic regression to test associations between participant characteristics and syringe/needle sharing. Results: The 1281 participants included 244 (19.0{\%}) individuals who reported injecting drugs in the past 6. months and 37.7{\%} of IDUs reported being HCV positive. During the six months preceding baseline assessment, the majority of IDUs reported obtaining sterile syringes from pharmacies (51.6{\%}) or syringe exchange programs (25.0{\%}), but fewer than half of IDUs always used a sterile syringe (46.9{\%}). More than one-third (38.5{\%}) shared syringe/needles with another injector in the past 6. months. Awareness of positive HCV vs. negative/unknown status was associated with increased recent syringe/needle sharing (aOR 2.37, 95{\%} CI 1.15, 4.88) in multivariable analysis. Conclusions: Risky injection behaviors remain prevalent and awareness of HCV infection was associated with increased risky injection behaviors. New approaches are needed to broadly implement HCV prevention interventions for IDUs seeking addiction treatment.",
keywords = "Alcoholism, Hepatitis C, Injection drug use, Opioid-related disorders, Syringe/needle sharing",
author = "Korthuis, {Philip (Todd)} and Feaster, {Daniel J.} and Gomez, {Zoilyn L.} and Moupali Das and Susan Tross and Katharina Wiest and Antoine Douaihy and Mandler, {Raul N.} and Sorensen, {James L.} and Grant Colfax and Dennis McCarty and Cohen, {Stephanie E.} and Penn, {Patricia E.} and Diane Lape and Metsch, {Lisa R.}",
year = "2012",
month = "4",
doi = "10.1016/j.addbeh.2011.12.001",
language = "English (US)",
volume = "37",
pages = "552--555",
journal = "Addictive Behaviors",
issn = "0306-4603",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Injection behaviors among injection drug users in treatment

T2 - The role of hepatitis C awareness

AU - Korthuis, Philip (Todd)

AU - Feaster, Daniel J.

AU - Gomez, Zoilyn L.

AU - Das, Moupali

AU - Tross, Susan

AU - Wiest, Katharina

AU - Douaihy, Antoine

AU - Mandler, Raul N.

AU - Sorensen, James L.

AU - Colfax, Grant

AU - McCarty, Dennis

AU - Cohen, Stephanie E.

AU - Penn, Patricia E.

AU - Lape, Diane

AU - Metsch, Lisa R.

PY - 2012/4

Y1 - 2012/4

N2 - Background: Injection drug use (IDU) is a primary vector for blood-borne infections. Awareness of Hepatitis C virus (HCV) infection status may affect risky injection behaviors. This study determines the prevalence of risky injection practices and examines associations between awareness of positive HCV status and risky injection behaviors. Methods: We surveyed individuals seeking treatment for substance use at 12 community treatment programs as part of a national HIV screening trial conducted within the National Drug Abuse Treatment Clinical Trials Network. Participants reported socio-demographic characteristics, substance use, risk behaviors, and HCV status. We used multivariable logistic regression to test associations between participant characteristics and syringe/needle sharing. Results: The 1281 participants included 244 (19.0%) individuals who reported injecting drugs in the past 6. months and 37.7% of IDUs reported being HCV positive. During the six months preceding baseline assessment, the majority of IDUs reported obtaining sterile syringes from pharmacies (51.6%) or syringe exchange programs (25.0%), but fewer than half of IDUs always used a sterile syringe (46.9%). More than one-third (38.5%) shared syringe/needles with another injector in the past 6. months. Awareness of positive HCV vs. negative/unknown status was associated with increased recent syringe/needle sharing (aOR 2.37, 95% CI 1.15, 4.88) in multivariable analysis. Conclusions: Risky injection behaviors remain prevalent and awareness of HCV infection was associated with increased risky injection behaviors. New approaches are needed to broadly implement HCV prevention interventions for IDUs seeking addiction treatment.

AB - Background: Injection drug use (IDU) is a primary vector for blood-borne infections. Awareness of Hepatitis C virus (HCV) infection status may affect risky injection behaviors. This study determines the prevalence of risky injection practices and examines associations between awareness of positive HCV status and risky injection behaviors. Methods: We surveyed individuals seeking treatment for substance use at 12 community treatment programs as part of a national HIV screening trial conducted within the National Drug Abuse Treatment Clinical Trials Network. Participants reported socio-demographic characteristics, substance use, risk behaviors, and HCV status. We used multivariable logistic regression to test associations between participant characteristics and syringe/needle sharing. Results: The 1281 participants included 244 (19.0%) individuals who reported injecting drugs in the past 6. months and 37.7% of IDUs reported being HCV positive. During the six months preceding baseline assessment, the majority of IDUs reported obtaining sterile syringes from pharmacies (51.6%) or syringe exchange programs (25.0%), but fewer than half of IDUs always used a sterile syringe (46.9%). More than one-third (38.5%) shared syringe/needles with another injector in the past 6. months. Awareness of positive HCV vs. negative/unknown status was associated with increased recent syringe/needle sharing (aOR 2.37, 95% CI 1.15, 4.88) in multivariable analysis. Conclusions: Risky injection behaviors remain prevalent and awareness of HCV infection was associated with increased risky injection behaviors. New approaches are needed to broadly implement HCV prevention interventions for IDUs seeking addiction treatment.

KW - Alcoholism

KW - Hepatitis C

KW - Injection drug use

KW - Opioid-related disorders

KW - Syringe/needle sharing

UR - http://www.scopus.com/inward/record.url?scp=84857048870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857048870&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2011.12.001

DO - 10.1016/j.addbeh.2011.12.001

M3 - Article

C2 - 22209655

AN - SCOPUS:84857048870

VL - 37

SP - 552

EP - 555

JO - Addictive Behaviors

JF - Addictive Behaviors

SN - 0306-4603

IS - 4

ER -